ReviewTranslational research : the journal of laboratory and clinical medicine2008
Translational approaches to addressing complex genetic pathways in colorectal cancer.
Review in Translational research : the journal of laboratory and clinical medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 14 citations in OpenAlex.
- Knockdown of linc-UFC1 suppresses proliferation and induces apoptosis of colorectal cancer.Cell death & disease · 2016Article
- LGR5 promotes the proliferation of colorectal cancer cells via the Wnt/β-catenin signaling pathway.Oncology letters · 2015Article
- A new insect cell line from pupal ovary of Spodoptera exigua established by stimulation with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).In vitro cellular & developmental biology. Animal · 2012Article
- Molecular events in primary and metastatic colorectal carcinoma: a review.Pathology research international · 2012Article
- Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin.International journal of colorectal disease · 2010Article
- Protein kinase C-beta II (PKC-beta II) expression in patients with colorectal cancer.International journal of colorectal disease · 2009Article
- Altered gene expression and miRNA expression associated with cancerous IEC-6 cell transformed by MNNG.Journal of experimental & clinical cancer research : CR · 2009Article
- Gene expression profiling: canonical molecular changes and clinicopathological features in sporadic colorectal cancers.World journal of gastroenterology · 2008Article
- Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract.World journal of gastroenterology · 2008Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 2 countries.
Funding
Abstract
Colorectal cancer (CRC) is among the most prevalent cancers worldwide and represents a major public health challenge in the developed world. From the perspective of translational investigation, scientists have enormous opportunity to elucidate the molecular genetic mechanisms that contribute to CRC pathogenesis because most cancers develop from adenomatous precursor lesions. The process of adenoma growth and transformation is accompanied by cumulative mutations in dominant genetic pathways that confer a growth advantage. Although this developmental process permits interrogation of informative pathways before the development of cancer, only a few adenomas progress to CRC. Accordingly, a major challenge for clinical translational investigators is to identify the molecular signatures that indicate increased likelihood for adenoma progression. By corollary, these molecular signatures include mutations in high penetrance alleles, which include the Adenomatous Polyposis Coli (APC) gene as well as other alleles in the Wnt/beta-catenin signaling pathway that specify increased genetic susceptibility to CRC. Interactions between these high penetrance alleles and other modifier genes as well as with environmental factors are of particular importance to understand the complex network of events that lead to CRC. This brief review will highlight 3 areas where important questions concerning genetic and environmental risk factors have fueled translational investigation into possible pathways that lead to CRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.